Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aker Solutions Awarded Major Offshore Wind Contract

July 19, 2021 – Aker Solutions, as part of a consortium, has signed a major[1] EPCI contract with an undisclosed customer to provide the HVDC (high-voltage, direct current) transmission system for a large offshore wind project. More details about the project is expected to be announced by the customer and its partners during the third quarter of 2021.For Aker Solutions, the scope will involve engineering, procurement, construction and installation (EPCI) of an offshore HVDC converter platform. This platform will consist of a steel jacket substructure and a topside platform deck housing the

Vitrolife’s share buyback program completed

During the period July 15, 2021 until July 16, 2021, Vitrolife AB (publ) has repurchased a total of 52,568 shares as part of the buyback program introduced by the Board of Directors to secure the obligations of Vitrolife (including social security contributions) relating to the long-term incentive program LTIP2021. As a result, the buyback program, which Vitrolife announced on July 14, 2021, is hereby completed since the maximum amount of shares (52,568) has been repurchased. The buyback program was carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and

Dentalum strengthens the Board of Directors with Mikael Lönn as new board member

At an extraordinary general meeting, Dentalum Operations AB (publ) elected Mikael Lönn as a new board member.Mikael Lönn is a medical doctor with vast experience as a business-leader and entrepreneur, mainly within the healthcare sector. In the late 1980s, Mikael founded and managed M&M Medical, a hospital group that operated Sabbatsberg and Täby hospital in Stockholm, which was later acquired by an international company. Since then, Mikael has been an active investor and a successful entrepreneur in various industries and has held board assignments at the Swedish dental service

Veoneer partners with Baraja to deliver Spectrum-Scan LiDAR for next generation autonomous vehicles

Stockholm, Sweden, July 19, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB) has signed an agreement with pioneering LiDAR company Baraja to industrialize their Spectrum-Scan™ LiDAR technology for the next market wave of L2+ through L4 autonomous vehicle applications.Under the non-exclusive agreement, Veoneer will develop, market and integrate a scalable Spectrum-Scan™ platform from Baraja to serve the automotive market. Veoneer chose to partner with Baraja after extensive testing, as Baraja offers robust technology and a roadmap that lends itself to be

2cureX receives important ISO 13485:2016 certification

2cureX has been certified for ISO 13485:2016 compliance - an important milestone in the company’s effort to bring 3D-microtumors to routine clinical practice, both from a regulatory and from a commercial perspective.In line with our strategy of becoming a full-fledged In Vitro Diagnostics (IVD) company 2cureX is happy to announce that we have been certified for ISO 13485:2016 compliance. Certification was issued by Bureau Veritas Certification Denmark A/S, a certification company accredited by DANAK. ISO 13485:2016 is the latest version of the standard for design, production,

Ideagen Boosts Offering with Two More Strategic Acquisitions

Leading provider of software solutions to companies operating in highly regulated industries, Ideagen PLC, has today announced it has made a further two acquisitions to increase its product offering.Ideagen’s strategy has been to grow geographically and by sector expertise and these two acquisitions are very much in line with that strategy, as they significantly add to Ideagen’s product offering and capabilities. The first acquisition, which was completed on Jul 9, is OpsBase, a UK-based health and safety compliance platform. The OpsBase platform will be a significant ad-on to Ideagen’s

Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”

Lund, Sweden, 19 July, 2021 - Clinical Laserthermia Systems AB  (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review article titled “Local Destruction of Tumors and Systemic Immune Effects”  has been published in the Journal “Frontiers in Oncology” by the company’s co-founder and Senior Clinical Advisor, Professor Karl-Göran Tranberg. Article Overview Current

Imfinzi approved in China for extensive-stage SCLC

19 July 2021 07:00 BST Imfinzi approved in China for the treatmentof extensive-stage small cell lung cancer Only PD-1/PD-L1 immunotherapy to demonstrate both a significant survival benefit and improved response rate in combination with a choice of chemotherapies AstraZeneca’s Imfinzi (durvalumab) has been approved in China for the 1st-line treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC), in combination with standard of care platinum chemotherapy (etoposide plus a choice of either carboplatin or cisplatin). The approval by China’s National

Peab rebuilds prison in Härnosand

Peab has been commissioned to rebuild and renovate the former prison in Härnösand. The customer is Intea Fastigheter and the contract is worth SEK 157 million.The Swedish Prison and Probation Service plans to reopen the prison in Härnösand. Intea Fastigheter owns the building and has awarded Peab the contract to refit the premises to meet current security class 2 standards and prepare space for the national transportation unit (NTE). The project includes rebuilding and renovating the facility - parts of which date back to the 1800s - to suit the incoming operations as well as maintenance

CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows

CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor to disrupt the field of cell line development (CLD). Microbioreactors have been instrumental in a string of research breakthroughs in CLD for a range of downstream applications, but with the addition of real-time

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2021

Stockholm, July 19, 2021. GomSpace Group AB (the “Company”) announces its interim report for the second quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April – 30 June 2021 (2020) · Order intake increased to T.SEK 199,459 (42,342) · Net revenues increased to T.SEK 47,535 (42,729) · Gross margin increased to 14% (11%) · Operating profit (loss) improved to a negative T.SEK 12,331 (a negative 14,859) · Earnings per share were a negative SEK 0.22 (a negative 0.

Quarterly Report Q2 2021

Significant sales growth and margin recoverySecond quarter · Net sales increased by 19% to SEK 23,648 M (19,953), with strong organic growth of 23% (–18) and acquired net growth of 5% (3). Currency effects amounted to –9% (0) · Very strong organic sales growth was reported by EMEIA, Americas, Entrance Systems and Global Technologies. The organic sales growth forAsia Pacific was stable · Four acquisitions with combined annual sales of about SEK 400 M were signed · Operating income (EBIT)[ ]increased by 71% and amounted to SEK 3,589 M (2,097), corresponding to an operating

Glycorex Transplantation AB (GTAB B): Universal Whole Blood: Presentation of results at two U.S. blood conferences

As previously announced, a leading center in the U.S. has tested our UBP-product for the manufacturing of universal whole blood. We can now announce that the results will be presented as poster presentations at the Society for the Advancement of Blood Management (SABM) and the AABB. In connection with these, abstracts will also be published in two different medical journals: "Anesthesia and Analgesia" and "Transfusion".Massive bleeding is one of the leading causes of death in severe trauma. Evidence is growing suggesting that transfusion of whole blood is most appropriate in these cases,

Elgood Development Well 48/22c-7 Flow Test Results

19 July 2021 IOG plc Successful Elgood Development Well 48/22c-7 Flow Test Results IOG plc (“IOG”, or “the Company”), (AIM: IOG.L), the UK gas company targeting growth and high returns via an infrastructure-led hub strategy, is pleased to provide an update on the Elgood well 48/22c-7, our first Phase 1 development well. The well was drilled horizontally through the reservoir section to a Total Depth of 15,472ft Measured Depth (MD), intersecting 1,080 ft of high-quality Permian Leman Sandstone reservoir along hole between 14,290 ft MD and 15,370 ft MD, with a net:gross ratio of

Coor acquires Veolia Technical Management

Coor today signed an agreement relating to the acquisition of the assets in the business area Veolia Technical Management, part of Veolia Sverige AB, which is divesting its operations in Sweden and Norway. The business area has some 250 employees and annual sales of some SEK 500 M. The acquisition further strengthens Coor’s offering and competencies in technical property services and maintenance.The purchase consideration totals SEK 180 M. The acquisition is financed within the framework of Coor’s existing financing in its entirety. The transaction takes the form of an asset transfer mainly

Nyfosa Finland aqcuires properties in Finland at a value of SEK 149 million

2021-07-19Nyfosa Finland has acquired a portfolio with industrial and retail properties in the Finnish regional cities of Oulu and Hyvinkää. The acquisition amounts to a total value of EUR 14.7 million, corresponding to approximately SEK 149 million.The five modern properties have a total area of approximately 9,000 square meters with an annual rental value of EUR 1.1 million, corresponding to approximately SEK 11.6 million. The portfolio is located in the regional cities of Oulu and Hyvinkää with two established tenants, Suomen Autokauppa Oy (SAKA) och Suomen Autohuolto Oy (SAH), focused

Nyfosa aqcuires property portfolio in Finland at a value of MSEK 149

Nyfosa has acquired a portfolio with industrial and retail properties in the Finnish regional cities of Oulu and Hyvinkää. The acquisition amounts to a total value of MEUR 14.7, corresponding to approximately MSEK 149.The five modern properties have a total area of approximately 9 thousand square meters with an annual rental value of MEUR 1.1, corresponding to approximately MSEK 11.6. The portfolio is located in the regional cities of Oulu and Hyvinkää with two established tenants, Soumen Autokauppa Oy (SAKA) och Soumen Autohoulto Oy (SAH), focused on car sales business and services. The

Skanska builds highway section in Czech Republic for EUR 77M, about SEK 780M

Skanska has signed a contract with National Highway Authority of the Czech Republic to build a highway section in Staré Město, eastern Czech Republic. The contract is worth EUR 77M, about SEK 780M, which will be included in the order bookings for Europe for the third quarter 2021.The construction of the 8.8-kilometer section between Staré Město – Moravský Písek, including nine bridges and two multi-level crossings, will be financed by the European Regional Development Fund, OP Integrated Infrastructure 2014-2020 and the state budget. The expected construction commencement date is August

Last day of trading and delisting of Aros Bostad's preference shares of class A

Today, 19 July 2021, is the last day of trading in Aros Bostadsutveckling AB's (publ) ("Aros Bostad" or the "Company") preference shares of class A, which today are also delisted from Nasdaq First North Growth Market.As the Company has previously communicated, the board of directors of the Company has resolved to redeem all 104,041 preference shares of class A. The redemption amount per share is, as stipulated in the articles of association, SEK 100, SEK 10,404,100 in total for all shares. Payment to holders of preference shares of class A on the record date 21 July 2021 is expected to

Interim Report 1 for the period 1 January - 30 June 2021

INCREASED FOCUS ON MARITIME AND ON ENSURED PROFITABILITY During the quarter, Climeon carried out commissioning for customers within both maritime and geothermal energy. Six modules were commissioned on Virgin Voyages' ship Valiant Lady and four Heat Power modules at the Flúðir power plant. Climeon's Icelandic customer Varmaorka has laid out a new plan for expansion of geothermal power plants, with a significantly lower roll-out rate for the coming years. As a consequence of this, Climeon has decided, after the end of the quarter, to reduce the order backlog by SEK 467.5 million to SEK 180.

Filo Mining Reports 1,378m at 0.71% CuEq; including 676m at 0.92% CuEq at Filo del Sol

Vancouver, BC, July 19, 2021 /CNW/ - Filo Mining Corp. (TSXV: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo Mining”, or the “Company”) is pleased to announce additional drill results from the Filo del Sol project in San Juan province, Argentina.  Highlights are listed below, along with accompanying figures: · Drillhole FSDH046 has returned the longest mineralized intersection on the project to date, was collared 200m to the east of FSDH032, and demonstrates strong mineralization to over 1,400m below surface. · FSDH046 returned 676m at 0.92% CuEq (0.57% Cu; 0.34g/

Fatty liver more common in children of mothers with obesity

Children and young people whose mothers had a BMI greater than 30 during early pregnancy are at an increased risk of fatty liver disease. This is shown in a register-based study from Karolinska Institutet and Harvard University published in the journal Journal of Hepatology. As obesity rates increase also in women at a child-bearing age, more and more young people are at risk of developing fatty liver disease, the researchers say.“The findings are important because obesity is becoming more common at a young age, and fatty liver due to being overweight, is increasing in the world. If a

There are no items matching the current filter
There are no more items matching the current filter
Back to top